Melatonin ameliorates chronic mild stress induced behavioral dysfunctions in mice

Physiology and Behavior

Volumn 119, Issue , 2013, Pages 201-207

  Haridas, Seenu ^a   Kumar, Mayank ^a   Manda, Kailash ^a  

^a INSTITUTE OF NUCLEAR MEDICINE AND ALLIED SCIENCES   (India)

Author keywords

Anxiety; Behavior; Chronic mild stress; Cognition; Depression; Melatonin

Indexed keywords

MELATONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; CHRONIC STRESS; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; MALE; MOUSE; NOCTURNAL ENURESIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; WEIGHT GAIN;

EID: 84880596965     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2013.06.015     Document Type: Article

References (54)

1. Kendler K.S., Karkowski L.M., Prescott C.A. The assessment of dependence in the study of stressful life events: validation using a twin design. Psychol Med 1999, 29:1455-1460.
2. Kessler R.C. The effects of stressful life events on depression. Annu Rev Psychol 1997, 48:191-214.
3. Willner P., Towell A., Sampson D., Sophokleous S., Muscat R. Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology 1987, 93:358-364.
4. Willner P. Validity, reliability and utility of the chronic mild stress (CMS) model of depression: a 10-year review and evaluation. Psychopharmacology (Berl) 1997, 134:319-329.
5. Willner P., Mitchell P.J. Animal models of depression: a diathesis-stress approach. Biol Psychiatry 2002, 2:701-726.
6. Strekalova T., Spanagel R., Bartsch D., Henn F., Gass P. Stress-induced anhedonia in mice is associated deficits in forced swimming and exploration. Neuropsychopharmacology 2004, 29:2007-2017.
7. Mineur Y.S., Belzung C., Crusio W.E. Effects of unpredictable chronic mild stress on anxiety and depression-like behavior in mice. Behav Brain Res 2006, 175:43-50.
8. Schweizer M.C., Henniger M.S.H., Sillaber I. Chronic mild stress (CMS) in mice: of anhedonia, 'anomalous anxiolysis' and activity. PLoS One 2009, e4326.
9. Willner P. Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 2005, 52:90-110.
10. Nemeroff C.B. The burden of severe depression: a review of diagnostic challenges and treatment alternatives. J Psychiatr Res 2007, 41:189-206.
11. Kennedy S.H. A review of antidepressant treatments today. Eur Neuropsychopharmacol 2006, 16:S619-S623.
12. Yu H.S., Tsin A.T.C., Reiter R.J. Melatonin: history, biosynthesis and assay methodology. Melatonin, biosynthesis, physiological effects, and clinical applications 1993, 1-16. CRC Press, Boca Raton, Florida. H.S. Yu, R.J. Reiter (Eds.).
13. Reiter R.J. Melatonin and human reproduction. Ann Med 1998, 30:103-108.
14. Waldhauzer F., Kovacs J., Reiter E. Age-related changes in melatonin levels in humans and its potential consequences for sleep disorders. Exp Gerontol 1998, 33:759-772.
15. Zhdanova I.V., Cantor M.L., Leclair O.U. Behavioral effect of melatonin treatment in non-human primates. Sleep Res Online 1998, 1:114-118.
16. Beck-Friis J., von Rosen D., Kjellman B.F., Ljunggren J.G., Wetterberg L. Melatonin in relation to body measures, sex, age, season and the use of drugs in patients with major affective disorders and healthy subjects. Psychoneuroendocrinology 1984, 9:261-277.
17. Pacchierotti C., Iapichino S., Bossini L., Pieraccini F., Castrogiovanni P. Melatonin in psychiatric disorders: a review on the melatonin involvement in psychiatry. Front Neuroendocrinol 2001, 22:18-32.
18. Crasson M., Kjiri S., Colin A., Kjiri K., L'Hermite-Baleriaux M., Ansseau M., et al. Serum melatonin and urinary 6-sulfatoxymelatonin in major depression. Psychoneuroendocrinology 2004, 29:1-12.
19. Potkin S.J., Zetin M., Stamenkovic V., Kripke D., Bunney W.E. Seasonal affective disorder: prevalence varies with latitude climate. Clin Neuropharmacol 1986, 9:181-183.
20. Terman M., Quitkin F.M., Terman J.S., Stewart J.W., McGrath P.J. The timing of phototherapy: effects on clinical response and the melatonin cycle. Psychopharmacol Bull 1987, 23:354-357.
21. Tsujimoto T., Yamada N., Shimoda K., Hanada K., Takahashi S. Circadian rhythms in depression. Part II: circadian rhythms in inpatients with various mental disorders. J Affect Disord 1990, 18:199-210.
22. Lader M. Limitations of current medical treatments for depression: disturbed circadian rhythms as a possible therapeutic target. Eur Neuropsychopharmacol 2007, 17:743-755.
23. Srinivasan V., Smits M., Spence W., Lowe A.D., Kayumov L., Pandi-Perumal S.R., et al. Melatonin in mood disorders. World J Biol Psychiatry 2006, 7:138-151.
24. Maldonado M.D., Pérez-San-Gregorio M.A., Reiter R.J. The role of melatonin in the immuno-neuro-psychology of mental disorders. Recent Pat CNS Drug Discov 2009, 4:61-69.
25. Reiter R.J., Benitez-King G. Melatonin reduces neuronal loss and cytoeskeletal deterioration: implications for psychiatry. Salud Mental 2009, 32:3-11.
26. Haridas S., Kumar M., Manda K. Chronic melatonin administration mitigates behavioral dysfunction induced by γ-irradiation. Horm Behav 2012, 62:621-627.
27. Porsolt R.D., Le Pichon M., Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 1977, 266:730-732.
28. Song L., Che W., Min-Wei W., Murakami Y., Matsumoto K. Impairment of the spatial learning and memory induced by learned helplessness and chronic mild stress. Pharmacol Biochem Behav 2006, 83:186-193.
29. Detanico B.C., Piato Â.L., Freitas J.J., Lhullier F.L., Hidalgo M.P., Caumo W., et al. Antidepressant-like effects of melatonin in the mouse chronic mild stress model. Eur J Pharmacol 2009, 607:121-125.
30. Katz R.J. Animal model of depression: pharmacological sensitivity of a hedonic deficit. Pharmacol Biochem Behav 1982, 16:965-968.
31. Harkin A., Houlihan D.D., Kelly J.P. Reduction in preference for saccharin by repeated unpredictable stress in mice and its prevention by imipramine. J Psychopharmacol 2002, 16:115-123.
32. Loiseau F., Le Bihan C., Hamon M., Thiébot M.H. Effects of melatonin and agomelatine in anxiety-related procedures in rats: interaction with diazepam. Eur Neuropsychopharmacol 2006, 16:417-428.
33. Gronli J., Murison R., Fiske E., Bjorvatn B., Sorensen E., Portas C.M., et al. Effects of chronic mild stress on sexual behavior, locomotor activity and consumption of sucrose and saccharine solutions. Physiol Behav 2005, 84:571-577.
34. D'Aquila P.S., Brain P., Willner P. Effects of chronic mild stress on performance in behavioural tests relevant to anxiety and depression. Physiol Behav 1994, 56:861-867.
35. Rossler A.S., Joubert C., Chapouthier G. Chronic mild stress alleviates anxious behaviour in female mice in two situations. Behav Processes 2000, 49:163-165.
36. Ducottet C., Belzung C. Behaviour in the elevated plus-maze predicts coping after subchronic mild stress in mice. Physiol Behav 2004, 81:417-426.
37. Solberg L.C., Horton T.H., Turek F.W. Circadian rhythms and depression: effects of exercise in an animal model. Am J Physiol 1999, 276:152-161.
38. Tannenbaum B., Tannenbaum G.S., Sudom K., Anisman H. Neurochemical and behavioural alterations elicited by a chronic intermittent stressor regimen: implications for allostatic load. Brain Res 2002, 953:82-92.
39. Gould E., Tanapat P., McEwen B.S., Flugge G., Fuchs E. Proliferation of granule cell precursors in the dentate gyrus of adult monkeys is diminished by stress. Proc Natl Acad Sci U S A 1998, 95:3168-3171.
40. McEwen B.S. Stress and hippocampal plasticity. Annu Rev Neurosci 1999, 22:105-122.
41. Kim M.J., Kim H.K., Kim B.S., Yim S.V. Melatonin increases cell proliferation in the dentate gyrus of maternally separated rats. J Pineal Res 2004, 37:193-197.
42. Moriya T., Horie N., Mitome M., Shinohara K. Melatonin influences the proliferative and differentiative activity of neural stem cells. J Pineal Res 2007, 42:411-418.
43. Ramirez-Rodriguez G., Klempin F., Babu H., Benitez-King G., Kempermann G. Melatonin modulates cell survival of new neurons in the hippocampus of adult mice. Neuropsychopharmacology 2009, 34:2180-2191.
44. Manda K., Ueno M., Anzai K. Space radiation-induced inhibition of neurogenesis in the hippocampal dentate gyrus and memory impairment in mice: ameliorative potential of the melatonin metabolite, AFMK. J Pineal Res 2008, 45:430-438.
45. Manda K., Uenob M., Anzai K. Cranial irradiation-induced inhibition of neurogenesis in hippocampal dentate gyrus of adult mice: attenuation by melatonin pretreatment. J Pineal Res 2009, 46:71-78.
46. Manda K., Reiter R.J. Melatonin maintains adult hippocampal neurogenesis and cognitive functions after irradiation. Prog Neurobiol 2010, 90:60-68.
47. Kopp C., Vogel E., Rettori M.C., Delagrange P., Misslin R. The effects of melatonin on the behavioural disturbances induced by chronic mild stress in C3H/He mice. Behav Pharmacol 1999, 10:73-83.
48. Micale V., Arezzi A., Rampello L., Drago F. Melatonin affects the immobility time of rats in the forced swim test: the role of serotonin neurotransmission. Eur Neuropsychopharmacol 2006, 16:538-545.
49. Imbesi M., Uz T., Yildiz S., Arslan A.D., Manev H. Drug- and region-specific effects of protracted antidepressant and cocaine treatment on the content of melatonin MT1 and MT2 receptor mRNA in the mouse brain. Int J Neuroprot Neuroregener 2006, 2(3):185-189.
50. Hirsch-Rodriguez E., Imbesi M., Manev R., Uz T., Manev H. The pattern of melatonin receptor expression in the brain may influence antidepressant treatment. Med Hypotheses 2007, 69:120-124.
51. Weil Z.M., Hotchkiss A.K., Gatien M.L., Pieke-Dahl S., Nelson R.J. Melatonin receptor (MT1) knockout mice display depression-like behaviours and deficits in sensorimotor gating. Brain Res Bull 2006, 68:425-429.
52. Arendt J. Melatonin and the pineal gland: influence on mammalian seasonal and circadian physiology. Rev Reprod 1998, 3:13-22.
53. Cardinali D.P., Srinivasan V., Brzezinski A., Brown G.M. Melatonin and its analogs in insomnia and depression. J Pineal Res 2012, 52:365-375.
54. Santarelli L., Saxe M., Gross C., Surget A., Battaglia F., Dulawa S., et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003, 301:805-809.